Companies / Recursion Pharmaceuticals, Inc.

Recursion Pharmaceuticals, Inc.

Nasdaq: RXRXCIK 1601830SALT LAKE CITY, UT

Financials · FY2025

Revenue$74.68M
Net income$-644.76M
Total debt$723.0K
Cash$545.68M
Diluted EPS$-1.44
Shares outstanding535.3M

Ownership

535.3M shares outstanding · as of Jul 31, 2026
2.5%Insiders
Ownership
Insiders2.48%13,251,367
10%+ / strategic10.92%58,481,102
Institutions55.61%297,697,449
Public float30.99%165,912,252

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Borgeson BlakeDirector
1.17%6,259,863
Khan NajatCEOCEO and President · Director
0.42%2,262,085
Li Dean YDirector
0.23%1,240,909
Taylor Ben RChief Financial Officer
0.22%1,180,318
Hallett DavidChief Scientific Officer
0.20%1,097,151
Gibson ChristopherDirector
0.17%906,556
Hershberg RobertDirector
0.03%162,156
Dar ZavainDirector
0.03%142,329

Institutional holders 343

View all →
HolderValue% of shares
Vanguard Group Inc$193.00M8.81%
BlackRock, Inc.$184.62M9.40%
ARK Investment Management LLC$152.63M6.97%
State Street Corporation$127.37M6.48%
BAILLIE GIFFORD & CO$72.68M4.42%
SoftBank Group Corp.$41.86M2.55%
MIC Capital Management UK LLP$39.44M1.80%
Geode Capital Management, LLC$37.69M2.29%
Sumitomo Mitsui Trust Group, Inc.$25.44M1.16%
Amova Asset Management Americas, Inc.$25.38M1.16%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jan 6, 2026Borgeson Blake
Director
SellClass A Common Stock$959.2K-220K
-3.20%
6,649,863
1.24% of shares
medium
Feb 3, 2026Borgeson Blake
Director
SellClass A Common Stock$924.0K-220K
-3.31%
6,429,863
1.20% of shares
medium
Mar 3, 2026Borgeson Blake
Director
SellClass A Common Stock$588.2K-170K
-2.64%
6,259,863
1.17% of shares
medium
Jan 20, 2026Gibson Christopher
Director
SellClass A Common Stock$178.8K-40K
-4.19%
913,839
0.17% of shares
medium
Jan 5, 2026Gibson Christopher
Director
SellClass A Common Stock$170.0K-40K
-4.11%
933,839
0.17% of shares
medium
Feb 4, 2026Gibson Christopher
Director
SellClass A Common Stock$164.8K-40K
-4.19%
913,839
0.17% of shares
medium
Feb 19, 2026Gibson Christopher
Director
SellClass A Common Stock$138.4K-40K
-4.23%
906,556
0.17% of shares
medium
Mar 23, 2026Gibson Christopher
Director
SellClass A Common Stock$130.0K-40K
-4.23%
906,556
0.17% of shares
medium

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
State Street CorporationPassive13G—34,706,130—
Vanguard Group IncPassive13G/A—0—
BAILLIE GIFFORD & COPassive13G/A—23,774,972—
ARK Investment Management LLCPassive13G/A———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
RXRX——75629V104—